| Item Type | Name |
|
Concept
|
Anti-HIV Agents
|
|
Academic Article
|
Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.
|
|
Academic Article
|
Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
|
|
Academic Article
|
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
|
|
Academic Article
|
Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.
|
|
Academic Article
|
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.
|
|
Academic Article
|
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.
|
|
Academic Article
|
Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation.
|
|
Academic Article
|
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
|
|
Academic Article
|
Chemokine analogues show suitable stability for development as microbicides.
|
|
Academic Article
|
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons.
|
|
Academic Article
|
Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels.
|
|
Academic Article
|
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.
|
|
Academic Article
|
Immune restoration following treatment. Abstract and Commentary.
|
|
Academic Article
|
Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.
|
|
Academic Article
|
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
|
|
Academic Article
|
Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.
|
|
Academic Article
|
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
|
|
Academic Article
|
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
|
|
Academic Article
|
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.
|
|
Academic Article
|
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
|
|
Academic Article
|
Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.
|
|
Academic Article
|
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replication.
|
|
Academic Article
|
The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
|
|
Academic Article
|
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.
|
|
Academic Article
|
Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative.
|
|
Academic Article
|
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.
|
|
Academic Article
|
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
|
|
Academic Article
|
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.
|
|
Academic Article
|
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
|
|
Academic Article
|
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
|
|
Academic Article
|
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
|
|
Academic Article
|
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.
|
|
Academic Article
|
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
|
|
Academic Article
|
Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection.
|
|
Academic Article
|
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
|
|
Academic Article
|
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
|
|
Academic Article
|
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
|
|
Academic Article
|
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
|
|
Academic Article
|
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.
|
|
Academic Article
|
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
|
|
Academic Article
|
Recovery of the immune system with antiretroviral therapy: the end of opportunism?
|
|
Academic Article
|
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.
|
|
Academic Article
|
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.
|
|
Academic Article
|
Older age is associated with peripheral blood expansion of na?ve B cells in HIV-infected subjects on antiretroviral therapy.
|
|
Academic Article
|
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
|
|
Academic Article
|
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
|
|
Academic Article
|
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.
|
|
Academic Article
|
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy.
|
|
Academic Article
|
Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.
|
|
Academic Article
|
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
|
|
Academic Article
|
HIV infection and aging of the innate immune system.
|
|
Academic Article
|
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.
|
|
Academic Article
|
Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures.
|
|
Academic Article
|
Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
|
|
Academic Article
|
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256.
|
|
Academic Article
|
Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy.
|
|
Academic Article
|
Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy.
|
|
Academic Article
|
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
|
|
Academic Article
|
Differential CD4+ cell count increase and CD4+?: ?CD8+ ratio normalization with maraviroc compared with tenofovir.
|
|
Academic Article
|
Immunological effects of antiretroviral and immune therapies for HIV.
|
|
Academic Article
|
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.
|
|
Academic Article
|
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
|
|
Academic Article
|
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.
|
|
Academic Article
|
Antigen-presenting cells in HIV pathogenesis and therapy: summary of the October 17-18, 2002, Think Tank meeting.
|
|
Academic Article
|
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
|
|
Academic Article
|
Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA).
|
|
Academic Article
|
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Na?ve to Antiretroviral Therapy: A Pilot Randomized Trial.
|
|
Academic Article
|
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
|
|
Academic Article
|
In vivo analysis of Fas/FasL interactions in HIV-infected patients.
|
|
Academic Article
|
Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.
|
|
Academic Article
|
Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy.
|
|
Academic Article
|
Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
|
|
Academic Article
|
Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.
|
|
Academic Article
|
Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor.
|
|
Academic Article
|
Vitamin D does not modulate immune-mediated bone loss during ART initiation.
|
|
Academic Article
|
Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment.
|
|
Academic Article
|
Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.
|
|
Academic Article
|
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
|
|
Academic Article
|
HIV and Aging in the Era of ART and COVID-19: Symposium Overview.
|